{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:16:08Z","timestamp":1791573368229,"version":"4.3.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T00:00:00Z","timestamp":1702425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T00:00:00Z","timestamp":1702425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81771239"],"award-info":[{"award-number":["81771239"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>Proinflammatory necroptosis is the main pathological mechanism of ischemic stroke. Homer scaffolding protein 1 (Homer1) is a postsynaptic scaffolding protein that exerts anti-inflammatory effects in most central nervous system diseases. However, the relationship between Homer1 and proinflammatory necroptosis in ischemic stroke remains unclear.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Aim<\/jats:title>\n                <jats:p>This study aimed to investigate the role of Homer1 in ischemia-induced necroptosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>C57BL\/6 mice were used to establish a model of permanent middle cerebral artery occlusion model (pMCAO). Homer1 knockdown mice were generated using adeno-associated virus (AAV) infection to explore the role of Homer1 and its impact on necroptosis in pMCAO. Finally, Homer1 protein was stereotaxically injected into the ischemic cortex of Homer1<jats:sup>flox\/flox<\/jats:sup>\/Nestin-Cre <jats:sup>+\/\u2212<\/jats:sup> mice, and the efficacy of Homer1 was investigated using behavioral assays and molecular biological assays to explore potential mechanisms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Homer1 expression peaked at 8\u00a0h in the ischemic penumbral cortex after pMCAO and colocalized with neurons. Homer1 knockdown promoted neuronal death by enhancing necroptotic signaling pathways and aggravating ischemic brain damage in mice. Furthermore, the knockdown of Homer1 enhanced the expression of proinflammatory cytokines. Moreover, injection of Homer1 protein reduced necroptosis-induced brain injury inhibited the expression of proinflammatory factors, and ameliorated the outcomes in the Homer1<jats:sup>flox\/flox<\/jats:sup>\/Nestin-Cre<jats:sup>+\/\u2212<\/jats:sup> mice after pMCAO.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Homer1 ameliorates ischemic stroke by inhibiting necroptosis-induced neuronal damage and neuroinflammation. These data suggested that Homer1 is a novel regulator of neuronal death and neuroinflammation.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00011-023-01824-x","type":"journal-article","created":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T14:02:31Z","timestamp":1702476151000},"page":"131-144","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Homer1 ameliorates ischemic stroke by inhibiting necroptosis-induced neuronal damage and neuroinflammation"],"prefix":"10.1007","volume":"73","author":[{"given":"Weihao","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuquan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,13]]},"reference":[{"key":"1824_CR1","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1021\/acscentsci.8b00230","volume":"4","author":"J Saraf","year":"2018","unstructured":"Saraf J, Bhattacharya P, Kalia K, Borah A, Sarmah D, Kaur H, et al. A friend or foe: calcineurin across the gamut of neurological disorders. ACS Cent Sci. 2018;4:805\u201319.","journal-title":"ACS Cent Sci"},{"key":"1824_CR2","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3389\/fnagi.2016.00191","volume":"8","author":"R Qiu","year":"2016","unstructured":"Qiu R, Gao Y, Hou D, Wang Y, Yu C, Wang W, et al. Association between hs-CRP levels and the outcomes of patients with small-artery occlusion. Front Aging Neurosci. 2016;8:191.","journal-title":"Front Aging Neurosci"},{"key":"1824_CR3","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3389\/fphar.2020.00059","volume":"11","author":"Y Zou","year":"2020","unstructured":"Zou Y, Hu J, Huang W, Ye S, Han F, Du J, et al. Non-mitogenic fibroblast growth factor 1 enhanced angiogenesis following ischemic stroke by regulating the sphingosine-1-phosphate 1 pathway. Front Pharmacol. 2020;11:59.","journal-title":"Front Pharmacol"},{"key":"1824_CR4","doi-asserted-by":"publisher","first-page":"6111","DOI":"10.7150\/thno.29435","volume":"8","author":"R Cao","year":"2018","unstructured":"Cao R, Li J, Kharel Y, Zhang C, Morris E, Santos WL, et al. Photoacoustic microscopy reveals the hemodynamic basis of sphingosine 1-phosphate-induced neuroprotection against ischemic stroke. Theranostics. 2018;8:6111\u201320.","journal-title":"Theranostics"},{"key":"1824_CR5","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1038\/s41467-020-17930-x","volume":"11","author":"X Ren","year":"2020","unstructured":"Ren X, Hu H, Farooqi I, Simpkins J. Blood substitution therapy rescues the brain of mice from ischemic damage. Nat Commun. 2020;11:4078.","journal-title":"Nat Commun"},{"key":"1824_CR6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0140-6736(19)31055-4","volume":"394","author":"H Rodgers","year":"2019","unstructured":"Rodgers H, Bosomworth H, Krebs H, van Wijck F, Howel D, Wilson N, et al. Robot assisted training for the upper limb after stroke (RATULS): a multicentre randomised controlled trial. Lancet (London, England). 2019;394:51\u201362.","journal-title":"Lancet (London, England)"},{"key":"1824_CR7","doi-asserted-by":"publisher","first-page":"2827580","DOI":"10.1155\/2018\/2827580","volume":"2018","author":"M Go\u0142\u0105b-Janowska","year":"2018","unstructured":"Go\u0142\u0105b-Janowska M, Paczkowska E, Machali\u0144ski B, Kotl\u0119ga D, Meller A, Safranow K, et al. Effects of angiotensin-converting enzyme inhibition on circulating endothelial progenitor cells in patients with acute ischemic stroke. Stem Cells Int. 2018;2018:2827580.","journal-title":"Stem Cells Int"},{"key":"1824_CR8","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1161\/CIRCRESAHA.116.308022","volume":"119","author":"D Petrovic-Djergovic","year":"2016","unstructured":"Petrovic-Djergovic D, Goonewardena S, Pinsky D. Inflammatory disequilibrium in stroke. Circ Res. 2016;119:142\u201358.","journal-title":"Circ Res"},{"key":"1824_CR9","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.neuropharm.2012.10.004","volume":"67","author":"F Atif","year":"2013","unstructured":"Atif F, Yousuf S, Sayeed I, Ishrat T, Hua F, Stein DG. Combination treatment with progesterone and vitamin D hormone is more effective than monotherapy in ischemic stroke: the role of BDNF\/TrkB\/Erk1\/2 signaling in neuroprotection. Neuropharmacology. 2013;67:78\u201387.","journal-title":"Neuropharmacology"},{"key":"1824_CR10","doi-asserted-by":"publisher","first-page":"14329","DOI":"10.1038\/ncomms14329","volume":"8","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Su SS, Zhao S, Yang Z, Zhong CQ, Chen X, et al. RIP1 autophosphorylation is promoted by mitochondrial ROS and is essential for RIP3 recruitment into necrosome. Nat Commun. 2017;8:14329.","journal-title":"Nat Commun"},{"key":"1824_CR11","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nchembio.83","volume":"4","author":"A Degterev","year":"2008","unstructured":"Degterev A, Hitomi J, Germscheid M, Ch\u2019en IL, Korkina O, Teng X, et al. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol. 2008;4:313\u201321.","journal-title":"Nat Chem Biol"},{"key":"1824_CR12","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ceb.2009.12.003","volume":"22","author":"DE Christofferson","year":"2010","unstructured":"Christofferson DE, Yuan J. Necroptosis as an alternative form of programmed cell death. Curr Opin Cell Biol. 2010;22:263\u20138.","journal-title":"Curr Opin Cell Biol"},{"key":"1824_CR13","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1038\/cdd.2016.46","volume":"23","author":"K Newton","year":"2016","unstructured":"Newton K, Dugger DL, Maltzman A, Greve JM, Hedehus M, Martin-McNulty B, et al. RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury. Cell Death Differ. 2016;23:1565\u201376.","journal-title":"Cell Death Differ"},{"key":"1824_CR14","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.tcb.2017.05.007","volume":"27","author":"MH Orzalli","year":"2017","unstructured":"Orzalli MH, Kagan JC. Apoptosis and necroptosis as host defense strategies to prevent viral infection. Trends Cell Biol. 2017;27:800\u20139.","journal-title":"Trends Cell Biol"},{"key":"1824_CR15","doi-asserted-by":"publisher","first-page":"807","DOI":"10.14336\/AD.2018.0728","volume":"10","author":"XX Deng","year":"2019","unstructured":"Deng XX, Li SS, Sun FY. Necrostatin-1 prevents necroptosis in brains after ischemic stroke via inhibition of RIPK1-mediated RIPK3\/MLKL signaling. Aging Dis. 2019;10:807\u201317.","journal-title":"Aging Dis"},{"key":"1824_CR16","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.2174\/1570159X16666180416152243","volume":"16","author":"H Jun-Long","year":"2018","unstructured":"Jun-Long H, Yi L, Bao-Lian Z, Jia-Si L, Ning Z, Zhou-Heng Y, et al. Necroptosis signaling pathways in stroke: from mechanisms to therapies. Curr Neuropharmacol. 2018;16:1327\u201339.","journal-title":"Curr Neuropharmacol"},{"key":"1824_CR17","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1002\/cne.20116","volume":"473","author":"Y Shiraishi","year":"2010","unstructured":"Shiraishi Y, Mizutani A, Yuasa S, Mikoshiba K, Furuichi T. Differential expression of Homer family proteins in the developing mouse brain. J Compar Neurol. 2010;473:582\u201399.","journal-title":"J Compar Neurol"},{"key":"1824_CR18","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nm1406","volume":"12","author":"A Tappe","year":"2006","unstructured":"Tappe A, Klugmann M, Luo C, Hirlinger D, Agarwal N, Benrath J, et al. Synaptic scaffolding protein Homer1a protects against chronic inflammatory pain. Nat Med. 2006;12:677\u201381.","journal-title":"Nat Med"},{"key":"1824_CR19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12974-022-02428-8","volume":"19","author":"X Fei","year":"2022","unstructured":"Fei X, Dou YN, Wang L, Wu X, Huan Y, Wu S, et al. Homer1 promotes the conversion of A1 astrocytes to A2 astrocytes and improves the recovery of transgenic mice after intracerebral hemorrhage. J Neuroinflamm. 2022;19:67.","journal-title":"J Neuroinflamm"},{"key":"1824_CR20","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1038\/s41418-018-0058-y","volume":"25","author":"R Zhang","year":"2018","unstructured":"Zhang R, Wu Y, Xie F, Zhong Y, Wang Y, Xu M, et al. RGMa mediates reactive astrogliosis and glial scar formation through TGF\u03b21\/Smad2\/3 signaling after stroke. Cell Death Differ. 2018;25:1503\u201316.","journal-title":"Cell Death Differ"},{"key":"1824_CR21","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.neuron.2010.12.004","volume":"69","author":"T Sasaki","year":"2011","unstructured":"Sasaki T, Takemori H, Yagita Y, Terasaki Y, Uebi T, Horike N, et al. SIK2 is a key regulator for neuronal survival after ischemia via TORC1-CREB. Neuron. 2011;69:106\u201319.","journal-title":"Neuron"},{"key":"1824_CR22","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/jcbfm.2010.181","volume":"31","author":"J Li","year":"2011","unstructured":"Li J, Siegel M, Yuan M, Zeng Z, Finnucan L, Persky R, et al. Estrogen enhances neurogenesis and behavioral recovery after stroke. J Cereb Blood Flow Metab. 2011;31:413\u201325.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1824_CR23","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1038\/s41467-020-15530-3","volume":"11","author":"ZX Xu","year":"2020","unstructured":"Xu ZX, Kim GH, Tan JW, Riso AE, Sun Y, Xu EY, et al. Elevated protein synthesis in microglia causes autism-like synaptic and behavioral aberrations. Nat Commun. 2020;11:1797.","journal-title":"Nat Commun"},{"key":"1824_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2022.04.007","volume":"492","author":"X Fei","year":"2022","unstructured":"Fei X, Dou YN, Lv W, Ding B, Wei J, Wu X, et al. TLR4 Deletion improves cognitive brain function and structure in aged mice. Neuroscience. 2022;492:1\u201317.","journal-title":"Neuroscience"},{"key":"1824_CR25","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41418-018-0195-3","volume":"26","author":"BL Heckmann","year":"2019","unstructured":"Heckmann BL, Tummers B, Green DR. Crashing the computer: apoptosis vs. necroptosis in neuroinflammation. Cell Death Differ. 2019;26:41\u201352.","journal-title":"Cell Death Differ"},{"key":"1824_CR26","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1182\/blood-2018-02-769026","volume":"132","author":"J Griffin","year":"2018","unstructured":"Griffin J, Zlokovic B, Mosnier L. Activated protein C, protease activated receptor 1, and neuroprotection. Blood. 2018;132:159\u201369.","journal-title":"Blood"},{"key":"1824_CR27","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.5551\/jat.53843","volume":"27","author":"M Peng","year":"2020","unstructured":"Peng M, Li X, Liu Y, Zou M, Xia Y, Xu G. Dietary glycemic index and glycemic load in relation to atherosclerotic stenosis of carotid and cardiovascular risk factors in ischemic stroke patients. J Atheroscler Thromb. 2020;27:1152\u20139.","journal-title":"J Atheroscler Thromb"},{"key":"1824_CR28","doi-asserted-by":"publisher","first-page":"4535","DOI":"10.7150\/thno.25674","volume":"8","author":"S Jiang","year":"2018","unstructured":"Jiang S, Li T, Ji T, Yi W, Yang Z, Wang S, et al. AMPK: potential therapeutic target for ischemic stroke. Theranostics. 2018;8:4535\u201351.","journal-title":"Theranostics"},{"key":"1824_CR29","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1161\/CIRCRESAHA.118.314518","volume":"124","author":"G Courties","year":"2019","unstructured":"Courties G, Frodermann V, Honold L, Zheng Y, Herisson F, Schloss MJ, et al. Glucocorticoids regulate bone marrow B lymphopoiesis after stroke. Circ Res. 2019;124:1372\u201385.","journal-title":"Circ Res"},{"key":"1824_CR30","doi-asserted-by":"publisher","first-page":"9452","DOI":"10.7150\/thno.62376","volume":"11","author":"C Xu","year":"2021","unstructured":"Xu C, Wu J, Wu Y, Ren Z, Yao Y, Chen G, et al. TNF-\u03b1-dependent neuronal necroptosis regulated in Alzheimer\u2019s disease by coordination of RIPK1-p62 complex with autophagic UVRAG. Theranostics. 2021;11:9452\u201369.","journal-title":"Theranostics"},{"key":"1824_CR31","doi-asserted-by":"publisher","first-page":"4457","DOI":"10.1038\/s41467-018-06985-6","volume":"9","author":"S Murai","year":"2018","unstructured":"Murai S, Yamaguchi Y, Shirasaki Y, Yamagishi M, Shindo R, Hildebrand JM, et al. A FRET biosensor for necroptosis uncovers two different modes of the release of DAMPs. Nat Commun. 2018;9:4457.","journal-title":"Nat Commun"},{"key":"1824_CR32","doi-asserted-by":"publisher","first-page":"eaaz9691","DOI":"10.1126\/sciadv.aaz9691","volume":"6","author":"S Kim","year":"2020","unstructured":"Kim S, Kim N, Lee J, Kim S, Hong J, Son S, et al. Dynamic Fas signaling network regulates neural stem cell proliferation and memory enhancement. Sci Adv. 2020;6:eaaz9691.","journal-title":"Sci Adv"},{"key":"1824_CR33","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.1161\/CIRCULATIONAHA.107.741645","volume":"117","author":"KK Koh","year":"2008","unstructured":"Koh KK, Park SM, Quon MJ. Leptin and cardiovascular disease: response to therapeutic interventions. Circulation. 2008;117:3238\u201349.","journal-title":"Circulation"},{"key":"1824_CR34","doi-asserted-by":"publisher","first-page":"4890","DOI":"10.1111\/ejn.14896","volume":"52","author":"WT Hung","year":"2020","unstructured":"Hung WT, Wang CH, Lin SY, Cheng SY, Liao LY, Lu LY, et al. Leptin protects brain from ischemia\/reperfusion-induced infarction by stabilizing the blood-brain barrier to block brain infiltration by the blood-borne neutrophils. Eur J Neurosci. 2020;52:4890\u2013907.","journal-title":"Eur J Neurosci"},{"key":"1824_CR35","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1001\/jamaneurol.2019.5061","volume":"77","author":"H Saber","year":"2020","unstructured":"Saber H, Saver JL. Distributional validity and prognostic power of the national institutes of health stroke scale in US administrative claims data. JAMA Neurol. 2020;77:606\u201312.","journal-title":"JAMA Neurol"},{"key":"1824_CR36","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1001\/jamaneurol.2017.2136","volume":"74","author":"WN Kernan","year":"2017","unstructured":"Kernan WN, Viscoli CM, Dearborn JL, Kent DM, Conwit R, Fayad P, et al. Targeting pioglitazone hydrochloride therapy after stroke or transient ischemic attack according to pretreatment risk for stroke or myocardial infarction. JAMA Neurol. 2017;74:1319\u201327.","journal-title":"JAMA Neurol"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-023-01824-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-023-01824-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-023-01824-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T04:23:58Z","timestamp":1704860638000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-023-01824-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,13]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["1824"],"URL":"https:\/\/doi.org\/10.1007\/s00011-023-01824-x","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,13]]},"assertion":[{"value":"10 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have declared that no competing interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}